DIAGNOS Will Utilize its Artificial Intelligence Medical Platform FLAIRE in Response to the US White House – Call to Action to Analyse and Transform…
Brossard, Quebec, March 25, 2020 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (DIAGNOS or the Corporation) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of Artificial Intelligence (AI), announces that it is participating in the Call to Action initiative implemented by the White House Office of Science and Technology Policy. DIAGNOS has accessed a significant dataset with the objective of analysing these medical documents with its AI Medical Platform, called FLAIRE, in order to identify key factors that could assist in the battle against the Coronavirus.
In response to the COVID-19 pandemic, the White House and a coalition of leading research groups have prepared the COVID-19 Open Research Dataset (CORD-19). CORD-19 is a resource of over 44,000 scholarly articles, including over 29,000 with full text, about COVID-19, SARS-CoV-2, and related coronaviruses. This dataset is provided to the global research community to apply recent advances in natural language processing and other AI techniques to generate new insights in support of the ongoing fight against this infectious disease. There is a growing urgency for these approaches because of the rapid acceleration in new coronavirus literature, making it difficult for the medical research community to keep up.
Call to Action (from the White House)
The White House is issuing a call to action to the world's artificial intelligence experts to develop text and data mining tools that can help the medical community develop answers to high priority scientific questions. The CORD-19 dataset represents the most extensive machine-readable coronavirus literature collection available for data mining to date. This allows the worldwide AI research community the opportunity to apply text and data mining approaches to find answers to questions within, and connect insights across, this content in support of the ongoing COVID-19 response efforts worldwide.
Mr. Andr Larente, CEO of Diagnos stated: Diagnos AI platform has been built to address the complexity of multiple sources of data that includes text mining, data mining and medical imaging. The proprietary technology has been developed over a number of years in order to identify medical challenges, for example cardio vascular issues have resulted in new tests to address hypertensive patient complications and to predict a potential stroke. The intention of FLAIRE in response to the White House Call to Action is to assist in resolving some of the issues caused by the virus by analyzing the dataset made available by the US authorities.
The Standing Committee on Emerging Infectious Disease and 21st Century Health Threats of the US and the WHO identified 10 scientific questions that are vital to address this international crisis. These questions include studying the transmission and incubation of the virus, risk factors for getting the COVID-19, the origin of the virus, and the proper medical practice for treating this disease.
Mr. Francis Bellido, PhD in Medical Microbiology and board member at Diagnos added: One outcome that is particularly remarkable in the COVID-19 crisis is that the majority of the deceased victims had one or several pre-condition(s) before the infection struck such as hypertension, diabetes, obesity or other Cardio Vascular issues, which are the sweet spots for the Diagnos diagnostic assisted platform. We believe that this virus could further alter the cartography of the retina in such patients, and if confirmed, creating the possibility of an additional facet to our existing detection tool for our existing patients.
Dr. Hadi Chakor, Chief Medical Officer at Diagnos added: One of the treatments for COVID-19 is the use of chloroquine or hydroxychloroquine. The recommendations of the American Academy of Ophthalmology on the screening of chloroquine (CQ) and hydroxychloroquine (HCQ) are very clear after taking high doses and for a long period of use, a rigorous follow-up with patients is required. These conditions represent the most severe risks of developing morphological alterations in the retina after treatment with chloroquine. Also, previous studies demonstrate clearly that chloroquine disrupts lysosomal function in retinal neurons and RPE. Modern screening should be based on primary AI-based automatic screening tests to assess the fundus plus optical spectral coherence tomography (SD OCT) exams. These investigations should look beyond the central macula to provide objective screening and to detect subtle changes on the retinal membrane.
The Corporation is also announcing a correction to its press release dated March 9th, 2020: The number of common shares that Mr. Tristram Coffin would hold assuming the exercise of stock warrants should read 11,047,561 instead of 10,624,560.About DIAGNOS
DIAGNOS is a publicly-traded Canadian corporation with a mission of early detection of critical health issues through the use of its Artificial Intelligence (AI) platform FLAIRE. Diagnos can build application rapidly using the FLAIRE platform such as CARA (Computer Assisted Retina Analysis). CARA is an application that integrates with existing equipment (hardware and software) and processes at the point of care. CARAs Artificial Intelligence image enhancement algorithms make standard retinal images sharper, clearer and easier to read. CARA is a cost-effective tool for screening large numbers of patients in real-time and has been cleared for commercialization by several regulatory authorities such as Health Canada, the U.S. Food and Drug Administration, European Union and other countries.
Additional information is available at http://www.diagnos.com and http://www.sedar.com.
This news release contains forward-looking information. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in these statements. DIAGNOS disclaims any intention or obligation to publically update or revise any forward-looking information, whether as a result of new information, future events or otherwise. The forward-looking information contained in this news release is expressly qualified by this cautionary statement.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information, please contact:
Go here to see the original:
DIAGNOS Will Utilize its Artificial Intelligence Medical Platform FLAIRE in Response to the US White House - Call to Action to Analyse and Transform...
- Senate bill targets the use of artificial intelligence in Mississippi - WAPT Jackson - March 15th, 2025 [March 15th, 2025]
- will.i.am and Sean Paul on embracing artificial intelligence in music - Sky News - March 15th, 2025 [March 15th, 2025]
- As Artificial Intelligence (AI) Stocks Fall, Investors Should Consider Buying More of These 2 Powerhouses - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- FSUs Graduate School hosts workshop on artificial intelligence to explore the impact of AI on teaching and research - Florida State News - March 15th, 2025 [March 15th, 2025]
- Artificial Intelligence Optimization (AIO): The Next Frontier in SEO - hackernoon.com - March 15th, 2025 [March 15th, 2025]
- The U.S. Army, Artificial Intelligence, and Mission Command - War On The Rocks - March 15th, 2025 [March 15th, 2025]
- 2 Stock-Split Artificial Intelligence (AI) Stocks to Buy Before They Zoom Higher, According to Wall Street Analysts - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- AI in the classroom: How artificial intelligence is helping teachers - Bay News 9 - March 15th, 2025 [March 15th, 2025]
- Video: Daryl Morey Says 76ers Use Artificial Intelligence for Input on Team Decisions - Bleacher Report - March 15th, 2025 [March 15th, 2025]
- Better Artificial Intelligence Stock: AT&T vs. Verizon Communications - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- NVIDIA GTC 25: What To Expect From the Years Biggest Artificial Intelligence Event - BizTech Magazine - March 15th, 2025 [March 15th, 2025]
- 2 Stock-Split Artificial Intelligence (AI) Stocks to Buy Before They Zoom Higher, According to Wall Street Analysts - MSN - March 15th, 2025 [March 15th, 2025]
- DEI Erosion Threatens Safety. Artificial Intelligence May Help Pick Up the Slack. - Inbound Logistics - March 15th, 2025 [March 15th, 2025]
- Saint Vincent conference will examine broad impact of artificial intelligence - TribLIVE - March 15th, 2025 [March 15th, 2025]
- As Artificial Intelligence (AI) Stocks Fall, Investors Should Consider Buying More of These 2 Powerhouses - MSN - March 15th, 2025 [March 15th, 2025]
- 3 Artificial Intelligence (AI) Stocks You Can Buy and Hold for the Next Decade - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- This Artificial Intelligence (AI) Stock Has Surged 1,000% Over the Past 2 Years. Is a Split on the Horizon? - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- Move Over, Artificial Intelligence (AI) -- Businesses Are on Pace to Spend More Than $10 Trillion on This Trend Over the Next Decade - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- Here Is My Top Artificial Intelligence (AI) Stock to Buy Right Now - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- Nasdaq Sell-Off: 2 Artificial Intelligence (AI) Stocks Down 20% and 49% to Buy Hand Over Fist on the Dip - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- 1 Top Artificial Intelligence (AI) Chip Stock to Buy Hand Over Fist Before It Jumps - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- [Latest] How Artificial Intelligence is Shaping the Emc Shielding And Test Equipment Market - openPR - March 15th, 2025 [March 15th, 2025]
- Nasdaq Correction: 5 Reasons Nvidia Stock Is Still a Top Artificial Intelligence (AI) Stock to Buy Right Now - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- Artificial Intelligence (AI) Adoption Rates Appear Low, but This Technology Leader Could See a Massive Surge in Demand in the Next 10 Years. Here's... - March 15th, 2025 [March 15th, 2025]
- [Latest] The Influence of Artificial Intelligence on the Augmented Reality (Ar) Shopping Market - openPR - March 15th, 2025 [March 15th, 2025]
- Oracle Just Shared Some Amazing News for the Entire Artificial Intelligence (AI) Industry - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- 1 No-Brainer Artificial Intelligence (AI) ETF to Buy With $40 During the Nasdaq Sell-Off - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- Inside The Artificial Intelligence That Can Clone Your Mind - Forbes - March 15th, 2025 [March 15th, 2025]
- Why Tesla Could Be a Massive Winner in the Artificial Intelligence (AI) Race - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- 4 Artificial Intelligence (AI) Stocks Worth Buying in the Tech Sell-Off - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- Impact of Artificial Intelligence (AI) on Media and Creative Industries - EDMO - March 1st, 2025 [March 1st, 2025]
- 1 Artificial Intelligence (AI) Stock That Could Be Bigger Than Nvidia in 5 Years - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- This Artificial Intelligence (AI) Stock Is Up 15% in 2025 Already. It Is Still a Solid Buy? - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- Can artificial intelligence be the future solution to the enormous challenges and suffering caused by Schizophrenia? - Nature.com - March 1st, 2025 [March 1st, 2025]
- Applications of Artificial Intelligence in Medical Education: A Systematic Review - Cureus - March 1st, 2025 [March 1st, 2025]
- This Artificial Intelligence (AI) Stock Is Up 15% in 2025 Already. It Is Still a Solid Buy? - AOL - March 1st, 2025 [March 1st, 2025]
- Federal Executive Forum Artificial Intelligence Strategies in Government Progress and Best Practices 2025 - Federal News Network - March 1st, 2025 [March 1st, 2025]
- Introduction to Artificial Intelligence for General Surgeons: A Narrative Review - Cureus - March 1st, 2025 [March 1st, 2025]
- How is Artificial Intelligence Affecting Health Care? - Workers Comp Forum - March 1st, 2025 [March 1st, 2025]
- 1 Spectacular Artificial Intelligence (AI) Stock to Buy With $50 Right Now - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- 20+ Advantages and Disadvantages of AI | Pros of Artificial Intelligence - Simplilearn - March 1st, 2025 [March 1st, 2025]
- Prediction: This Top Artificial Intelligence (AI) Stock Will Start Skyrocketing After March 6 - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- 1 Surprising Stock Harnessing the Power of Artificial Intelligence (AI) - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- 2 Top Artificial Intelligence (AI) Stocks to Buy On the Dip Amid Nasdaq Selloff - Yahoo Finance - March 1st, 2025 [March 1st, 2025]
- Review: Artificial intelligence is shaping the future of diabetes care - News-Medical.Net - March 1st, 2025 [March 1st, 2025]
- Prediction: This Artificial Intelligence (AI) Stock -- a 1,020% Gainer Since Its IPO -- Won't Split Its Stock in 2025. Here's Why - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- A Nobel laureate on the economics of artificial intelligence - MIT Technology Review - March 1st, 2025 [March 1st, 2025]
- Prediction: This Top Artificial Intelligence (AI) Stock Will Start Skyrocketing After March 6 - Nasdaq - March 1st, 2025 [March 1st, 2025]
- Meta Platforms Just Caused This Crucial Artificial Intelligence (AI) Stock to Plummet. Should You Buy the Dip? - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- Artificial Intelligence - AI Update, February 28, 2025: AI News and Views From the Past Week - MarketingProfs.com - March 1st, 2025 [March 1st, 2025]
- The Ultimate Artificial Intelligence (AI) ETF to Buy With $50 Right Now - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- Prediction: This Artificial Intelligence (AI) Company Will Split Its Stock in 2025 - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- Should You Forget Nvidia and Buy 2 Artificial Intelligence (AI) Stocks Instead? - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- Why Artificial Intelligence Stocks SoundHound AI, IonQ, and C3.ai Are Struggling Today - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- 2 Top Artificial Intelligence (AI) Stocks Ready for a Bull Run - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- AI Cant Do This Anymore: The Dangers of Artificial Intelligence in Academia - Skidmore News - March 1st, 2025 [March 1st, 2025]
- Whats Next in Artificial Intelligence: Agents that can do more than chatbots - Pittsburgh Post-Gazette - February 9th, 2025 [February 9th, 2025]
- Geopolitics of artificial intelligence to be focus of major summit in Paris; AP explains - Yahoo - February 9th, 2025 [February 9th, 2025]
- Geopolitics of artificial intelligence to be focus of major summit in Paris; AP explains - The Associated Press - February 9th, 2025 [February 9th, 2025]
- 3 Top Artificial Intelligence Stocks to Buy in February - MSN - February 9th, 2025 [February 9th, 2025]
- Geopolitics of artificial intelligence to be focus of major summit in Paris; AP explains - Lufkin Daily News - February 9th, 2025 [February 9th, 2025]
- 2 of the Hottest Artificial Intelligence (AI) Stocks on the Planet Can Plunge Up to 94%, According to Select Wall Street Analysts - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- These 2 Stocks Are Leading the Data Center Artificial Intelligence (AI) Trend, but Are They Buys Right Now? - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- Book Review | Genesis: Artificial Intelligence, Hope, and the Human Spirit - LSE - February 9th, 2025 [February 9th, 2025]
- The Artificial Intelligence Action Summit In France: Maintaining The Dialogue On Global AI Regulation - Forrester - February 9th, 2025 [February 9th, 2025]
- Is prediction the next frontier for artificial intelligence? - Healthcare IT News - February 9th, 2025 [February 9th, 2025]
- The Artificial Intelligence in Medicines Market Is Set to Reach $18,119 Million | CAGR of 49.6% - openPR - February 9th, 2025 [February 9th, 2025]
- Geopolitics of artificial intelligence to be focus of major summit in Paris; AP explains - The Audubon County Advocate Journal - February 9th, 2025 [February 9th, 2025]
- Around and About with Richard McCarthy: Asking AI about itself: Will artificial intelligence ever surpass humankind? - GazetteNET - February 9th, 2025 [February 9th, 2025]
- Will the Paris artificial intelligence summit set a unified approach to AI governanceor just be another conference? - Bulletin of the Atomic... - February 9th, 2025 [February 9th, 2025]
- Apple Stock Jumps on Artificial Intelligence (AI) Driving iPhone Sales. Here's Why It's Not Getting Crushed by the DeepSeek Launch. - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- Who will win the race to Artificial General Intelligence? - The Indian Express - February 9th, 2025 [February 9th, 2025]
- Prediction: This Artificial Intelligence (AI) Chip Stock Will Win Big From DeepSeek's Feat - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- Prediction: 2 Artificial Intelligence (AI) Stocks That Will Be Worth More Than Nvidia 3 Years From Now - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- State of Louisiana Launches Innovation Brand, Announces Creation of $50 Million Growth Fund and Artificial Intelligence Research Institute - Louisiana... - February 9th, 2025 [February 9th, 2025]
- Using smart technologies and artificial intelligence in food packaging can reduce food waste - Yahoo News Canada - February 9th, 2025 [February 9th, 2025]
- BigBear.ai Wins Department of Defense Contract to Prototype Near-Peer Adversary Geopolitical Risk Analysis for Chief Digital and Artificial... - February 9th, 2025 [February 9th, 2025]
- Should Investors Change Their Artificial Intelligence (AI) Investment Strategy After the DeepSeek Launch? - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- 1 Unstoppable Artificial Intelligence (AI) Stock to Buy Before It Punches Its Ticket to the $4 Trillion Club - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- Got 10 Years and $1000? These 3 Artificial Intelligence (AI) Stocks Are Set to Soar. - The Motley Fool - February 9th, 2025 [February 9th, 2025]